Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-18

Clinical Trial Update: Imaging of Solid Tumors Using 18F-TRX [Phase 1]

View source ↗

Summary

A Phase 1 study is evaluating imaging of solid tumors with the radiotracer 18F-TRX. The trial is currently recruiting and includes prostate cancer, renal cell c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 18F-TRX (18F-TRX radiotracer)

Snippet

Sponsor: Rahul Aggarwal | Conditions: Solid Tumor, Solid Carcinoma | Phase 1 | Status: RECRUITING